Search results
Repare Therapeutics appoints new board member By Investing.com
Investing.com· 2 hours agoDr. Stein's inclusion comes as Repare continues to expand its pipeline of cancer treatments. With a...
Novan (NASDAQ:NOVN) Coverage Initiated at StockNews.com
ETF DAILY NEWS· 2 days agoInvestment analysts at StockNews.com assumed coverage on shares of Novan (NASDAQ:NOVN – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating ...
Earnings call: Novartis reports strong Q1 with upgraded full-year guidance By Investing.com
Investing.com· 2 days agoNovartis AG (SIX:NOVN) has delivered a robust financial performance in the first quarter of 2024,...
Arvinas Inc (ARVN) Stock Sees a-2.89 Decrease – News Heater
NewsHeater· 16 hours agoIn the past week, ARVN stock has gone down by -7.84%, with a monthly decline of -22.93% and a quarterly plunge of -16.34%. The volatility ratio for the week is 4.09%, and the volatility levels ...
Morning Bid: Tanking Tesla reports, Europe business beats By Reuters
Investing.com· 4 days agoMorning Bid: Tanking Tesla reports, Europe business beats
Novartis lifts guidance after Q1 results beat expectations
Reuters· 4 days ago, opens new tab on Tuesday raised its full-year guidance after reporting better-than-expected...
Trending tickers: Tesla, ABF, Novartis, Taylor Wimpey, JD Sports
Yahoo Finance UK· 4 days agoShares were almost 10% higher on the back of the news. Novartis (NOVN.SW) Swiss drugmaker Novartis...
Earnings call: ServiceNow reports robust Q1 2024 results, Gen AI adoption soars By Investing.com
Investing.com· 1 day agoServiceNow (NYSE: NYSE:NOW) has announced its first quarter results for 2024, surpassing...
Novartis accused of promoting asthma drug for preterm labor despite brain risk
Reuters· 3 days ago, opens new tab has been hit with a lawsuit by people with autism and their mothers alleging the...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology By Reuters
Investing.com· 1 day agoGSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent...